Cancer is an evolutionary process fueled by genetic or epigenetic alterations in the genome.Understanding the evolutionary dynamics that are operative at different stages of tumor progression might inform effective st...Cancer is an evolutionary process fueled by genetic or epigenetic alterations in the genome.Understanding the evolutionary dynamics that are operative at different stages of tumor progression might inform effective strategies in early detection,diagnosis,and treatment of cancer.However,our understanding on the dynamics of tumor evolution through time is very limited since it is usually impossible to sample patient tumors repeatedly.The recent advances in in vitro 3D organoid culture technologies have opened new avenues for the development of more realistic human cancer models that mimic many in vivo biological characteristics in human tumors.Here,we review recent progresses and challenges in cancer genomic evolution studies and advantages of using tumor organoids to study cancer evolution.We propose to establish an experimental evolution model based on continuous passages of patient-derived organoids and longitudinal sampling to study clonal dynamics and evolutionary patterns over time.Development and integration of population genetic theories and computational models into time-course genomic data in tumor organoids will help to pinpoint the key cellular mechanisms underlying cancer evolutionary dynamics,thus providing novel insights on therapeutic strategies for highly dynamic and heterogeneous tumors.展开更多
基金supported by the grants from the Natural Science Foundation of Guangdong(2021B1515020042 to Z.H.)SIAT Innovation Program for Excellent Young Researchers(E1G053 to Z.L.)China Postdoctoral Science Foundation(2021M693303 to Z.L.)。
文摘Cancer is an evolutionary process fueled by genetic or epigenetic alterations in the genome.Understanding the evolutionary dynamics that are operative at different stages of tumor progression might inform effective strategies in early detection,diagnosis,and treatment of cancer.However,our understanding on the dynamics of tumor evolution through time is very limited since it is usually impossible to sample patient tumors repeatedly.The recent advances in in vitro 3D organoid culture technologies have opened new avenues for the development of more realistic human cancer models that mimic many in vivo biological characteristics in human tumors.Here,we review recent progresses and challenges in cancer genomic evolution studies and advantages of using tumor organoids to study cancer evolution.We propose to establish an experimental evolution model based on continuous passages of patient-derived organoids and longitudinal sampling to study clonal dynamics and evolutionary patterns over time.Development and integration of population genetic theories and computational models into time-course genomic data in tumor organoids will help to pinpoint the key cellular mechanisms underlying cancer evolutionary dynamics,thus providing novel insights on therapeutic strategies for highly dynamic and heterogeneous tumors.
